Abstract:Recent biomedical discoveries have revolutionized the concept and understanding of carcinogenesis, a complex and multistep phenomenon which involves accretion of genetic, epigenetic, biochemical, and histological changes, with special reference to MicroRNAs (miRNAs) and cancer stem cells (CSCs). miRNAs are small noncoding molecules known to regulate expression of more than 60% of the human genes, and their aberrant expression has been associated with the pathogenesis of human cancers and the regulation of stemness features of CSCs. CSCs are the small population of cells present in human malignancies well-known for cancer resistance, relapse, tumorigenesis, and poor clinical outcome which compels the development of novel and effective therapeutic protocols for better clinical outcome. Interestingly, the role of miRNAs in maintaining and regulating the functioning of CSCs through targeting various oncogenic signaling pathways, such as Notch, wingless (WNT)/β-Catenin, janus kinases/ signal transducer and activator of transcription (JAK/STAT), phosphatidylinositol 3-kinase/ protein kinase B (PI3/AKT), and nuclear factor kappa-light-chain-enhancer of activated B (NF-kB), is critical and poses a huge challenge to cancer treatment. Based on recent findings, here, we have documented the regulatory action or the underlying mechanisms of how miRNAs affect the signaling pathways attributed to stemness features of CSCs, such as self-renewal, differentiation, epithelial to mesenchymal transition (EMT), metastasis, resistance and recurrence etc., associated with the pathogenesis of various types of human malignancies including colorectal cancer, lung cancer, breast cancer, head and neck cancer, prostate cancer, liver cancer, etc. We also shed light on the fact that the targeted attenuation of deregulated functioning of miRNA related to stemness in human carcinogenesis could be a viable approach for cancer treatment.

Association between lncRNAs with stem cells in cancer; a particular focus on lncRNA-CSCs axis in cancer immunopathogenesis

LncRNAs and their role in cancer stem cells

The missing link between cancer stem cells and immunotherapy

Targeting cancer stem cells in cancer therapy

Long non-coding RNAs: Emerging regulators for chemo/immunotherapy resistance in cancer stem cells

Cancer stem cells: The important role of CD markers, Signaling pathways, and MicroRNAs

Propagation and Maintenance of Cancer Stem Cells: A Major Influence of the Long Non-Coding RNA H19

Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies

Long Non-Coding RNAs as Regulators for Targeting Breast Cancer Stem Cells and Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential

Role of microRNAs in the Regulation of Breast Cancer Stem Cells

microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities

The Roles of Ncrnas and Histone-Modifiers in Regulating Breast Cancer Stem Cells

LncRNAs, the Molecules Involved in Communications With Colorectal Cancer Stem Cells

Cancer Stemness Meets Immunity: From Mechanism to Therapy

Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development

Complex interaction and heterogeneity among cancer stem cells in head and neck squamous cell carcinoma revealed by single-cell sequencing

Breast cancer stem cells: current advances and clinical implications.

Lung cancer stem cells: tools and targets to fight lung cancer

Breast Cancer Stem Cells, Cytokine Networks, and the Tumor Microenvironment

Characterization of Cancer Stem Cells in Laryngeal Squamous Cell Carcinoma by Single-Cell RNA Sequencing

Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review